← FDA Drug Approvals (Drugs@FDA)

ACETAZOLAMIDE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-06-17

Drug application

FDA Application #
ANDA219775
Application type
Abbreviated New Drug Application (Generic)
Brand name
ACETAZOLAMIDE SODIUM
Generic name
ACETAZOLAMIDE SODIUM
Active ingredients
ACETAZOLAMIDE SODIUM
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Sagent Pharmaceuticals
First approval
2025-06-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown